Page 8 - Oncology Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Open-Analysis Platform for Pediatric Brain Tumors Offers Data Resource for Cancer Research

miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesAtlas openJo lynne rokitaChildren brain tumor networkOncology consortiumBrain tumor networkPacific pediatric neuro oncology consortiumPediatric brain tumor atlasOpen pediatric brain tumor atlasSupervisory bioinformatics scientistData driven discovery

First-of-its-kind open-analysis platform for

Researchers have partnered to create a first-of-its-kind open-source, reproducible analysis platform for pediatric brain tumors. With the help of thousands of genomically sequenced samples, researchers have used this platform to identify initial findings about genetic variants associated with poorer outcomes that could help guide future diagnostic and therapeutic advances.

United statesSan franciscoNew jerseyJo lynne rokitaAnna kinderkrebsforschungAtlas openAlexandra alex scottJay scottJaclynn taroniNational institutes of healthGenetics of the national cancer instituteNational cancer instituteChildren hospital of philadelphia division neurosurgeryChildhood cancer data labOncology consortiumMethod of research

KAZIA CEO, DR JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE CANCER MOONSHOT

/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, has been invited to the White House to.

White houseDistrict of columbiaUnited statesNew south walesJane loweJoe bidenJohn friendJill bidenCancer moonshot brain cancers forum on glioblastomaSociety for melanoma researchPrnewswire kazia therapeutics limitedKazia therapeutics limitedOncology consortiumGlobal coalition for adaptive researchAmerican association for cancer researchKazia therapeutics

Personalis, (PSNL) ABRCC and Criterium Announce Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer

Personalis, (PSNL) ABRCC and Criterium Announce Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRuth stoneClaire wyntersRichard chenPavani chalasaniAcademic gi cancer consortiumAcademic thoracic oncology medical investigators consortiumGeorge washington cancer centerPersonalis incAcademic myeloma consortium amyGeorge washington universityExchange commissionAcademic breast cancer consortiumAcademic urology research investigators consortiumOncology consortiumBreast cancer minimal residual disease detection

Student art auction to raise funds for neuroscience research

In 2021, local teens and friends Bridget Liu and Maya Sriram found a way to channel their shared love for art and science by founding the Neuroscience Art Auction, in

Maya sriramLos altos high schoolLos altos community centerLos altos community center sequoia roomOncology consortiumBridget liuNeuroscience art auctionMountain viewSilicon valleyLos altosLos altos highCupertino highPediatric neuro oncology consortiumLos altos high schoolMountain view los altos high school district